PubMed:10449169
Annnotations
Inflammaging
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-61 | Sentence | denotes | Dendritic cells and the pathogenesis of rheumatoid arthritis. |
| T2 | 62-203 | Sentence | denotes | Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory disease in which unknown arthrogenic autoantigen is presented to CD4+ T cells. |
| T3 | 204-382 | Sentence | denotes | The strong association of the disease with an epitope within the HLA-DR chain shared between various alleles of HLA-DR4 and DR1 emphasizes the importance of antigen presentation. |
| T4 | 383-565 | Sentence | denotes | This immune response predominantly occurs in the synovial tissue and fluid of the joints and autoreactive T cells are readily demonstrable in both the synovial compartment and blood. |
| T5 | 566-682 | Sentence | denotes | Circulating dendritic cells (DC) are phenotypically and functionally identical with normal peripheral blood (PB) DC. |
| T6 | 683-850 | Sentence | denotes | In the synovial tissue, fully differentiated perivascular DC are found in close association with T cells and with B cell follicles, sometimes containing follicular DC. |
| T7 | 851-1035 | Sentence | denotes | These perivascular DC migrate across the activated endothelium from blood and receive differentiative signals within the joint from monocyte-derived cytokines and CD40-ligand+ T cells. |
| T8 | 1036-1134 | Sentence | denotes | In the SF, DC manifest an intermediate phenotype, similar to that of monocyte-derived DC in vitro. |
| T9 | 1135-1234 | Sentence | denotes | Like a delayed-type hypersensitivity response, the rheumatoid synovium represents an effector site. |
| T10 | 1235-1327 | Sentence | denotes | DC at many effector sites have a characteristic pattern of infiltration and differentiation. |
| T11 | 1328-1430 | Sentence | denotes | It is important to note that the effector response is not self-limiting in RA autoimmune inflammation. |
| T12 | 1431-1599 | Sentence | denotes | In this article, we argue that the presentation of self-antigen by DC and by autoantibody-producing B cells is critical for the perpetuation of the autoimmune response. |
| T13 | 1600-1738 | Sentence | denotes | Permanently arresting this ongoing immune response with either pharmaceutical agents or immunotherapy is a major challenge for immunology. |
| T1 | 0-61 | Sentence | denotes | Dendritic cells and the pathogenesis of rheumatoid arthritis. |
| T2 | 62-203 | Sentence | denotes | Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory disease in which unknown arthrogenic autoantigen is presented to CD4+ T cells. |
| T3 | 204-382 | Sentence | denotes | The strong association of the disease with an epitope within the HLA-DR chain shared between various alleles of HLA-DR4 and DR1 emphasizes the importance of antigen presentation. |
| T4 | 383-565 | Sentence | denotes | This immune response predominantly occurs in the synovial tissue and fluid of the joints and autoreactive T cells are readily demonstrable in both the synovial compartment and blood. |
| T5 | 566-682 | Sentence | denotes | Circulating dendritic cells (DC) are phenotypically and functionally identical with normal peripheral blood (PB) DC. |
| T6 | 683-850 | Sentence | denotes | In the synovial tissue, fully differentiated perivascular DC are found in close association with T cells and with B cell follicles, sometimes containing follicular DC. |
| T7 | 851-1035 | Sentence | denotes | These perivascular DC migrate across the activated endothelium from blood and receive differentiative signals within the joint from monocyte-derived cytokines and CD40-ligand+ T cells. |
| T8 | 1036-1134 | Sentence | denotes | In the SF, DC manifest an intermediate phenotype, similar to that of monocyte-derived DC in vitro. |
| T9 | 1135-1234 | Sentence | denotes | Like a delayed-type hypersensitivity response, the rheumatoid synovium represents an effector site. |
| T10 | 1235-1327 | Sentence | denotes | DC at many effector sites have a characteristic pattern of infiltration and differentiation. |
| T11 | 1328-1430 | Sentence | denotes | It is important to note that the effector response is not self-limiting in RA autoimmune inflammation. |
| T12 | 1431-1599 | Sentence | denotes | In this article, we argue that the presentation of self-antigen by DC and by autoantibody-producing B cells is critical for the perpetuation of the autoimmune response. |
| T13 | 1600-1738 | Sentence | denotes | Permanently arresting this ongoing immune response with either pharmaceutical agents or immunotherapy is a major challenge for immunology. |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 62-82 | HP_0001370 | denotes | Rheumatoid arthritis |
| T2 | 73-82 | HP_0001369 | denotes | arthritis |
| T3 | 101-111 | HP_0002960 | denotes | autoimmune |
| T4 | 1406-1416 | HP_0002960 | denotes | autoimmune |
| T5 | 1579-1589 | HP_0002960 | denotes | autoimmune |
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-15 | cell_type | denotes | Dendritic cells |
| T2 | 150-173 | protein | denotes | arthrogenic autoantigen |
| T3 | 190-202 | cell_type | denotes | CD4+ T cells |
| T4 | 250-257 | protein | denotes | epitope |
| T5 | 269-281 | protein | denotes | HLA-DR chain |
| T6 | 316-323 | protein | denotes | HLA-DR4 |
| T7 | 328-331 | protein | denotes | DR1 |
| T8 | 476-496 | cell_type | denotes | autoreactive T cells |
| T9 | 566-593 | cell_type | denotes | Circulating dendritic cells |
| T10 | 595-597 | cell_type | denotes | DC |
| T11 | 650-681 | cell_type | denotes | normal peripheral blood (PB) DC |
| T12 | 728-743 | cell_type | denotes | perivascular DC |
| T13 | 780-787 | cell_type | denotes | T cells |
| T14 | 797-813 | cell_type | denotes | B cell follicles |
| T15 | 836-849 | cell_type | denotes | follicular DC |
| T16 | 857-872 | cell_type | denotes | perivascular DC |
| T17 | 983-1009 | protein | denotes | monocyte-derived cytokines |
| T18 | 1014-1034 | cell_type | denotes | CD40-ligand+ T cells |
| T19 | 1047-1049 | cell_type | denotes | DC |
| T20 | 1105-1124 | cell_type | denotes | monocyte-derived DC |
| T21 | 1482-1494 | protein | denotes | self-antigen |
| T22 | 1498-1500 | cell_type | denotes | DC |
| T23 | 1508-1538 | cell_type | denotes | autoantibody-producing B cells |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C20 | 0-15 | NP | denotes | Dendritic cells |
| C24 | 62-87 | NP | denotes | Rheumatoid arthritis (RA) |
| C21 | 91-132 | NP | denotes | a chronic autoimmune inflammatory disease |
| C22 | 136-141 | NP | denotes | which |
| C23 | 230-241 | NP | denotes | the disease |
| C26 | 428-447 | NP | denotes | the synovial tissue |
| C5 | 566-598 | NP | denotes | Circulating dendritic cells (DC) |
| C30 | 650-681 | NP | denotes | normal peripheral blood (PB) DC |
| C27 | 686-705 | NP | denotes | the synovial tissue |
| C11 | 707-743 | NP | denotes | fully differentiated perivascular DC |
| C10 | 851-872 | NP | denotes | These perivascular DC |
| C13 | 1047-1049 | NP | denotes | DC |
| C28 | 1059-1084 | NP | denotes | an intermediate phenotype |
| C29 | 1097-1101 | NP | denotes | that |
| C18 | 1235-1237 | NP | denotes | DC |
| C19 | 1498-1500 | NP | denotes | DC |
| R1 | C22 | C21 | coref-relat | which,a chronic autoimmune inflammatory disease |
| R2 | C23 | C24 | coref-ident | the disease,Rheumatoid arthritis (RA) |
| R3 | C5 | C20 | coref-other | Circulating dendritic cells (DC),Dendritic cells |
| R4 | C30 | C5 | coref-ident | normal peripheral blood (PB) DC,Circulating dendritic cells (DC) |
| R5 | C27 | C26 | coref-ident | the synovial tissue,the synovial tissue |
| R6 | C10 | C11 | coref-ident | These perivascular DC,fully differentiated perivascular DC |
| R7 | C13 | C20 | coref-ident | DC,Dendritic cells |
| R8 | C29 | C28 | coref-pron | that,an intermediate phenotype |
| R9 | C18 | C13 | coref-ident | DC,DC |
| R10 | C19 | C18 | coref-ident | DC,DC |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-61 | Sentence | denotes | Dendritic cells and the pathogenesis of rheumatoid arthritis. |
| S2 | 62-203 | Sentence | denotes | Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory disease in which unknown arthrogenic autoantigen is presented to CD4+ T cells. |
| S3 | 204-382 | Sentence | denotes | The strong association of the disease with an epitope within the HLA-DR chain shared between various alleles of HLA-DR4 and DR1 emphasizes the importance of antigen presentation. |
| S4 | 383-565 | Sentence | denotes | This immune response predominantly occurs in the synovial tissue and fluid of the joints and autoreactive T cells are readily demonstrable in both the synovial compartment and blood. |
| S5 | 566-682 | Sentence | denotes | Circulating dendritic cells (DC) are phenotypically and functionally identical with normal peripheral blood (PB) DC. |
| S6 | 683-850 | Sentence | denotes | In the synovial tissue, fully differentiated perivascular DC are found in close association with T cells and with B cell follicles, sometimes containing follicular DC. |
| S7 | 851-1035 | Sentence | denotes | These perivascular DC migrate across the activated endothelium from blood and receive differentiative signals within the joint from monocyte-derived cytokines and CD40-ligand+ T cells. |
| S8 | 1036-1134 | Sentence | denotes | In the SF, DC manifest an intermediate phenotype, similar to that of monocyte-derived DC in vitro. |
| S9 | 1135-1234 | Sentence | denotes | Like a delayed-type hypersensitivity response, the rheumatoid synovium represents an effector site. |
| S10 | 1235-1327 | Sentence | denotes | DC at many effector sites have a characteristic pattern of infiltration and differentiation. |
| S11 | 1328-1430 | Sentence | denotes | It is important to note that the effector response is not self-limiting in RA autoimmune inflammation. |
| S12 | 1431-1599 | Sentence | denotes | In this article, we argue that the presentation of self-antigen by DC and by autoantibody-producing B cells is critical for the perpetuation of the autoimmune response. |
| S13 | 1600-1738 | Sentence | denotes | Permanently arresting this ongoing immune response with either pharmaceutical agents or immunotherapy is a major challenge for immunology. |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-15 | cell_type | denotes | Dendritic cells |
| T2 | 62-82 | other_name | denotes | Rheumatoid arthritis |
| T3 | 84-86 | other_name | denotes | RA |
| T4 | 93-132 | other_name | denotes | chronic autoimmune inflammatory disease |
| T5 | 150-173 | protein_molecule | denotes | arthrogenic autoantigen |
| T6 | 190-193 | protein_molecule | denotes | CD4 |
| T7 | 250-257 | protein_domain_or_region | denotes | epitope |
| T8 | 269-281 | protein_subunit | denotes | HLA-DR chain |
| T9 | 316-323 | protein_molecule | denotes | HLA-DR4 |
| T10 | 328-331 | protein_molecule | denotes | DR1 |
| T11 | 361-381 | other_name | denotes | antigen presentation |
| T12 | 432-447 | tissue | denotes | synovial tissue |
| T13 | 476-488 | cell_type | denotes | autoreactive |
| T14 | 489-496 | cell_type | denotes | T cells |
| T15 | 534-554 | tissue | denotes | synovial compartment |
| T16 | 559-564 | tissue | denotes | blood |
| T17 | 566-593 | cell_type | denotes | Circulating dendritic cells |
| T18 | 595-597 | cell_type | denotes | DC |
| T19 | 650-673 | tissue | denotes | normal peripheral blood |
| T20 | 675-677 | tissue | denotes | PB |
| T21 | 679-681 | cell_type | denotes | DC |
| T22 | 690-705 | tissue | denotes | synovial tissue |
| T23 | 728-743 | cell_type | denotes | perivascular DC |
| T24 | 780-787 | cell_type | denotes | T cells |
| T25 | 797-813 | cell_type | denotes | B cell follicles |
| T26 | 836-849 | cell_type | denotes | follicular DC |
| T27 | 857-872 | cell_type | denotes | perivascular DC |
| T28 | 892-913 | tissue | denotes | activated endothelium |
| T29 | 919-924 | tissue | denotes | blood |
| T30 | 983-1009 | protein_family_or_group | denotes | monocyte-derived cytokines |
| T31 | 1014-1018 | protein_molecule | denotes | CD40 |
| T32 | 1027-1034 | cell_type | denotes | T cells |
| T33 | 1047-1049 | cell_type | denotes | DC |
| T34 | 1105-1124 | cell_type | denotes | monocyte-derived DC |
| T35 | 1142-1180 | other_name | denotes | delayed-type hypersensitivity response |
| T36 | 1186-1205 | tissue | denotes | rheumatoid synovium |
| T37 | 1294-1306 | other_name | denotes | infiltration |
| T38 | 1311-1326 | other_name | denotes | differentiation |
| T39 | 1403-1405 | other_name | denotes | RA |
| T40 | 1482-1494 | protein_molecule | denotes | self-antigen |
| T41 | 1498-1500 | cell_type | denotes | DC |
| T42 | 1508-1530 | cell_type | denotes | autoantibody-producing |
| T43 | 1531-1538 | cell_type | denotes | B cells |
| T44 | 1579-1598 | other_name | denotes | autoimmune response |
| T45 | 1663-1684 | other_organic_compound | denotes | pharmaceutical agents |
| T46 | 1688-1701 | other_name | denotes | immunotherapy |
| T47 | 1727-1737 | other_name | denotes | immunology |